Why Does My Scan Show Fatty Liver When I Don’t Drink Alcohol?
How fat collects in the liver, what a routine scan can tell you and why checking for scarring matters.
About 8 minutes to read · Patient education
The curious one
The explainer
The line on the scan report
Suresh has an ultrasound while his clinician investigates a bout of abdominal discomfort. On the way home, he opens the report and sees “fatty liver.” He reads it twice. At the follow-up visit, his first question is the one he’s been carrying around all week. “How can that happen? I don’t drink.”
Fat can collect inside liver cells even in someone who drinks no alcohol. One common reason is a change in how the body handles sugar and fat. When liver fat occurs alongside certain metabolic risk factors, such as type 2 diabetes or high blood pressure, and alcohol intake is below defined levels, the condition is often called metabolic dysfunction-associated steatotic liver disease, or MASLD. Older reports may use the term NAFLD. [1][2][3]
The scan tells Suresh there may be extra fat in the liver. The next questions are why it’s there and whether there’s any sign of scarring. Fatty liver often causes few or no symptoms, so his clinician also considers other explanations for the discomfort that led to the scan. [2][4][5]
How does fat end up inside liver cells?
The liver receives nutrients from the gut and helps you store, make and distribute fuel. It can take in fatty acids released from body fat or supplied by food. It can also make new fat from other nutrients. When more fat is supplied or made than the liver can use or send out, some can build up in the cells. [2][6]
Insulin normally helps regulate blood sugar and keeps some of the body’s stored fat from being released between meals. With insulin resistance, tissues respond less well to that signal. More fatty acids can reach the liver, and the liver can continue making fat. These are some of the ways insulin resistance connects type 2 diabetes and metabolic fatty liver. [2][5][6]
Think of the liver as a place where fuel comes in, gets used or goes out again. The ultrasound caught a sign of fuel accumulating. It takes more information to understand which parts of that process contributed in Suresh’s case. [4][5]
Can I have fatty liver at a normal weight?
Type 2 diabetes and extra fat around the waist increase the chance of metabolic fatty liver. High triglycerides, high blood pressure or low HDL cholesterol can also be clues to the wider metabolic pattern. A person can have MASLD even if their weight falls in the usual range for their height. Body fat distribution and inherited factors can matter too. [1][2][7]
Suresh’s clinician asks about alcohol in the same way she asks about medicines, family history and past illnesses. The answers help identify possible causes, including causes that can coexist. Some medicines and less common inherited or metabolic conditions can contribute to fatty liver. Depending on the history and blood tests, the clinician may also check for other liver diseases, such as viral hepatitis. [2][4][5][7]
If you bring the scan report to a visit, bring your medicine and supplement list and any recent blood sugar or cholesterol results too. That gives your clinician a fuller picture than a weight or an ultrasound finding on its own. [2][4]
Is liver fat the same thing as liver damage?
Extra fat inside liver cells is called steatosis. Some people have steatosis with little evidence of liver injury. In others, there is also inflammation and damage to liver cells. That form is called metabolic dysfunction-associated steatohepatitis, or MASH. Older reports may call it NASH. [1][2][3]
Injury can lead to fibrosis, the medical term for scarring. Over time, extensive scarring can change the structure of the liver and make it harder for blood to flow through it. That advanced stage is called cirrhosis. People can remain at an early stage for years, and the pace of progression varies. [2][3][8]
Suresh asks whether “mild fatty liver” means mild scarring. On a routine ultrasound, the description is about how the liver looks and how much fat the scan appears to show. Estimating scar risk takes different information. That distinction helps explain why a clinician may investigate further even when the word “mild” appears in the report. [2][4][5]
Which tests tell me whether there is scarring?
A routine ultrasound can suggest extra fat, but it can miss smaller amounts and cannot reliably measure fibrosis. Liver enzyme tests such as ALT and AST provide clues about injury. Those tests may be within the usual range even when someone has important scarring. The clinician looks at the wider pattern. [2][4][5]
One common first step in adults is a score called FIB-4. It uses age, AST, ALT and the platelet count. The score helps identify people who may need more testing for advanced scarring. Age and the circumstances of the blood test affect the interpretation, so ask what the result means for you. [2][5]
If more information is needed, a clinician may arrange elastography. This estimates how stiff the liver is, often with an ultrasound-based device. Scarring can increase stiffness. A specialist can interpret a raised or unclear result, and some people need a liver biopsy. Many can be assessed with blood tests and imaging. [2][4][5]
At the follow-up, Suresh wants to know whether he needs another ultrasound next month. His clinician explains that if the first assessment suggests a low risk of advanced scarring, follow-up may involve repeating the blood-based risk assessment later. The interval depends on factors such as whether he has diabetes and how many other metabolic risks he has. Ask what result would change the plan. [2][5]
Can the liver improve?
For people with excess weight, gradual, sustained weight loss can reduce liver fat. Larger sustained changes may help inflammation and scarring in some people. Regular physical activity can also help reduce liver fat, even if the change on the scale is small. For people at a healthy weight, the plan may focus on eating habits, activity and the metabolic risks that need attention. [2][7][9]
In a year-long study of people with MASH confirmed by biopsy, 90% of those who lost at least 10% of their weight no longer had steatohepatitis on a repeat biopsy. Fibrosis improved in 45% of that subgroup. The study followed people in a lifestyle programme. People weren’t randomly assigned to lose different amounts, and these results are group findings for a specific set of patients. [10]
Suresh asks what progress would look like for him. They agree to review his blood sugar, activity and liver results at follow-up. The goal includes improving the conditions that affect his liver and heart. [2][5]
What can I change in a normal week?
Suresh starts with a change he can picture doing. He orders water instead of a sweetened drink at lunch and walks after work on days he gets home early. A pattern with more vegetables, pulses, whole grains and unsaturated fats, and fewer sugary drinks and highly processed foods, can support liver and metabolic health. Choose an activity and eating plan that fit your health and circumstances. [2][9][11]
Ask what to do about blood sugar, cholesterol and blood pressure. Managing these is part of fatty liver care because cardiovascular disease is a major risk for people with MASLD. Some people with MASH and significant scarring may qualify for specialist treatment. A fatty appearance on ultrasound alone doesn’t determine whether those medicines are appropriate. [2][5][12]
Discuss any supplement marketed as a liver cleanse before taking it. Some products can harm the liver. Ask your clinician when to repeat tests and what would prompt a specialist referral. [2][9]
When should I get help sooner?
An incidental finding of fatty liver usually calls for a planned review. Bring the scan and ask what might be causing the fat, what your risk of scarring is and when to follow up. New symptoms can change how quickly you need care. [2][4][5]
Get emergency medical help for vomiting blood or material that looks like coffee grounds, passing black, tarry stools, or sudden confusion or severe drowsiness. In someone with advanced liver disease, these may signal serious complications. They can have other causes and need urgent care either way. [8][13][14]
Seek urgent medical assessment for new yellowing of the eyes or skin, or new swelling of the abdomen. If you feel severely unwell or have the emergency signs above, call your local emergency number. [8][13][15]
Suresh still doesn’t drink. He now understands why his clinician asked about his blood sugar, waist and medicines. The scan started a conversation about his liver and the rest of his health.
The fridge-door cheat sheet
Important patient-education notice
General information only. Use this article to discuss liver scan findings, diagnosis and care with your clinician. Ask them before changing any medicine. For severe symptoms, call your local emergency number immediately.
The evidence file
Checked 15 November 2026. This article draws on clinical guidelines, consensus statements, patient guidance and primary research. Older sources use the terms NAFLD and NASH. The weight-loss figures describe a subgroup in a prospective lifestyle study. Suresh, Zappy and Prof. Bolt are fictional, and their dialogue is invented. The drawings are explanatory sketches.
- Rinella and colleagues — Multisociety consensus on fatty liver nomenclature — 2023 international consensus on the terms MASLD and MASH and their diagnostic framework.
- EASL, EASD and EASO — Clinical Practice Guidelines on MASLD — 2024 clinical guideline on mechanisms, risk assessment, fibrosis testing and management.
- NIH/NIDDK — Definition & Facts of NAFLD & NASH — Patient guide on steatosis, steatohepatitis and long-term complications.
- NIH/NIDDK — Diagnosis of NAFLD & NASH — Patient guide on history, blood tests, imaging, elastography and biopsy.
- AASLD — Practice Guidance on Clinical Assessment and Management of NAFLD — 2023 guidance on secondary causes, liver enzyme and ultrasound limitations, and noninvasive fibrosis assessment.
- Donnelly and colleagues — Sources of fatty acids stored in liver in people with NAFLD — 2005 primary tracer study identifying contributions from circulating fatty acids, diet and fat made in the liver.
- American Gastroenterological Association — NAFLD in Lean Individuals — 2022 practice update on risk, other causes, evaluation and management in people without excess body weight.
- NIH — Cirrhosis of the Liver — Patient guide on advanced scarring, effects on blood flow, abdominal swelling, bleeding and confusion.
- NIH/NIDDK — Treatment for NAFLD & NASH — Patient guide on sustainable weight management, exercise and supplement cautions.
- Vilar-Gomez and colleagues — Weight Loss Through Lifestyle Modification Significantly Reduces Features of NASH — 2015 prospective lifestyle study with repeat biopsies. Reports inflammation and fibrosis outcomes among participants who achieved different weight changes.
- NIH/NIDDK — Eating, Diet, & Nutrition for NAFLD & NASH — Patient guide on food patterns, fats and reducing sugary drinks.
- Updated Global Consensus Recommendations for MASLD — 2026 clinical consensus on fibrosis risk and selecting patients for specialist treatment.
- NHS — Cirrhosis — Patient guide to urgent and emergency symptoms in people with advanced liver disease.
- NIH/NIDDK — Symptoms & Causes of GI Bleeding — Patient safety guidance on bloody or coffee-ground vomit and black, tarry stools.
- NHS — Jaundice — Patient safety guidance on urgent assessment for yellowing of the eyes or skin.